Pfizer, the company hit with the largest healthcare fraud settlement and criminal fine to date in 2009; which also happens to be the same company behind the first every mRNA gene therapy injection administered to the general public under emergency use authorisation in the name of Covid-19, has admitted in confidential documents, that it desperately tried to keep from going public, that its Covid-19 mRNA gene therapy may cause Vaccine-Associated Enhanced Disease.
This article is a report of the original article published 3rd Feb 22. We have republished because Twitter have decided to censor the original link because they want to control what you are allowed to know about.
Since the year 2000, Pfizer have been hit with fines to the amount of at least £7.5 billion, including a single £331.5 million fine for kickbacks and bribery offences, £1.1 billion in fines for false claims offences, and a record breaking individual £1.7 billion fine in 2009 for engaging in fraud by mispromoting a now withdrawn painkiller.
But despite all this the company was still trusted enough by medicine regulators around the world to be granted emerged use authorisation for its experimental Covid-19 injection. Perhaps the company may be incurring some more large fines for kickbacks and bribery offences in the near future?
But we doubt they’ll care much when they made approximately $36 billion dollars in 2021 thanks to Governments worldwide using the hardworking tax payers money to purchase enough doses of their Covid-19 “vaccine” to vaccinate every citizen seven times.
Now, according to confidential documents authored by Pfizer that it wanted to deperately keep secret, the company hasn’t just caused damage to the public purse, it appears it has also caused damage to the publics health, because Pfizer admit that Vaccine-Associated Enhanced Disease is a a very real theoretical risk for its Covid-19 vaccine.
The confidential document titled ‘5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT
REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021‘, was submitted by Pfizer-BioNTech as part of its Biological License Application (BLA) to the U.S. Federal Drug Administration (FDA)
Table 5, found on page 11 of the document shows an ‘Important Potential Risk’, and that risk is listed as ‘Vaccine-Associated Enhanced Disease (VAED), including Vaccine-Associated Enhanced Reporatory Disease (VAERD)’.